We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

arGEN-X N.V. Presents the Results of Phase I Study of ARGX-111 at ASCO

News   May 29, 2015

 
arGEN-X N.V. Presents the Results of Phase I Study of ARGX-111 at ASCO
 
 
Advertisement
 

RELATED ARTICLES

Ancient DNA Provides Insights on How Tuberculosis Shaped the Human Immune System

News

COVID-19 is only the latest infectious disease to have had an outsized impact on human life. A new study employing ancient human DNA reveals how tuberculosis has affected European populations over the past 2,000 years, specifically the impact that disease has had on the human genome.

READ MORE

Accurately Assessing the Transmissibility of New Virus Mutants

News

An international team including researchers from Bern has now been able to demonstrate in both the laboratory and in animal models why the D614G variant was able to gain the upper hand over the original SARS-CoV-2 virus.

READ MORE

Nanoparticle-Infused Contact Lenses Correct Color Blindness

News

Dyed contact lenses currently in development for color blindness are potentially harmful and unstable. Now, researchers have infused contact lenses with gold nanoparticles to create a safer way to see colors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE